Your browser doesn't support javascript.
loading
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
Canti, Lorenzo; Humblet-Baron, Stéphanie; Desombere, Isabelle; Neumann, Julika; Pannus, Pieter; Heyndrickx, Leo; Henry, Aurélie; Servais, Sophie; Willems, Evelyne; Ehx, Grégory; Goriely, Stanislas; Seidel, Laurence; Michiels, Johan; Willems, Betty; Liston, Adrian; Ariën, Kevin K; Beguin, Yves; Goossens, Maria E; Marchant, Arnaud; Baron, Frédéric.
Afiliação
  • Canti L; Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Liege, Belgium.
  • Humblet-Baron S; Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
  • Desombere I; SD Infectious Diseases in Humans, Sciensano, 642 Engelandstraat, 1180, Ukkel, Belgium.
  • Neumann J; Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
  • Pannus P; SD Infectious Diseases in Humans, Sciensano, 642 Engelandstraat, 1180, Ukkel, Belgium.
  • Heyndrickx L; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, 155 Nationalestraat, 2000, Antwerp, Belgium.
  • Henry A; Division of Hematology, Department of Medicine, CHU of Liège, Liège, Belgium.
  • Servais S; Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Liege, Belgium.
  • Willems E; Division of Hematology, Department of Medicine, CHU of Liège, Liège, Belgium.
  • Ehx G; Division of Hematology, Department of Medicine, CHU of Liège, Liège, Belgium.
  • Goriely S; Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Liege, Belgium.
  • Seidel L; Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Gosselies, Belgium.
  • Michiels J; Department of Biostatistics, University Hospital of Liège, Liège, Belgium.
  • Willems B; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, 155 Nationalestraat, 2000, Antwerp, Belgium.
  • Liston A; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, 155 Nationalestraat, 2000, Antwerp, Belgium.
  • Ariën KK; Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, KU Leuven, Leuven, Belgium.
  • Beguin Y; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, UK.
  • Goossens ME; Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, 155 Nationalestraat, 2000, Antwerp, Belgium.
  • Marchant A; Laboratory of Hematology, GIGA-I3, University of Liege and CHU of Liège, Liege, Belgium.
  • Baron F; Division of Hematology, Department of Medicine, CHU of Liège, Liège, Belgium.
J Hematol Oncol ; 14(1): 174, 2021 10 24.
Article em En | MEDLINE | ID: mdl-34689821

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Anticorpos Neutralizantes / Vacinas contra COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Anticorpos Neutralizantes / Vacinas contra COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Reino Unido